Qi Zhang sees himself as a warrior. In his lab at the University of North Carolina at Chapel Hill, he wages war on genetic diseases such as cancer and heart disease on a battlefield measured with single atoms. In a paper published by the ...
Tags: genetic diseases, RNA, nuclear magnetic resonance spectroscopy
US-based biopharmaceutical firm Anacor Pharmaceuticals has received a $13.5m research contract from the US Department of Defense, Defense Threat Reduction Agency (DTRA) to design and discover new classes of systemic antibiotics. Research ...
ProMining Therapeutics and Roche have collaborated for the discovery of small molecule therapeutics against type 2 diabetes mellitus. According to the deal, ProMining will use its CavitIIRx platform in the discovery programme and will ...
Tags: collaboration, small molecule therapeutics, medical technology
Full Spectrum Genetics and BioBlocks have signed an agreement to find new Small Molecule Therapeutics for protein-protein interactions As part of the agreement, Full Spectrum Genetics protein analysis and engineering platform, MapEng, and ...
Tags: Full Spectrum Genetics, BioBlocks, new small molecule therapeutics
AstraZeneca and Ardelyx have signed a worldwide exclusive licensing agreement for Ardelyx's NHE3 inhibitor programme for the treatment of complications associated with end-stage renal disease (ESRD) and chronic kidney disease (CKD). The ...
Tags: RDX5791, Ardelyx, AstraZeneca, NHE3 inhibitor programme, NHE3
AstraZeneca, a biopharmaceutical company, has completed the purchase of a US-based biotechnology company, Ardea Biosciences. Upon completion of the merger, approved by Ardea's stockholders, each outstanding share of Ardea common stock has ...
Tags: purchase, AstraZeneca, Ardea Biosciences, biopharmaceutical